Global Biosimilar Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Date : Jan 2019

Formats :
Report Code : PMR103885654

Category : Pharmaceutical and Healthcare
No Of Pages : 135

Global Biosimilar Market Overview:

A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.


This report focuses on the Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Biosimilar is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new Planet Market Reports study.

Market Segment by Manufacturers, this report covers


Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics SA
Boehringer Ingelheim GmbH
Celltrion Inc.
Coherus BioSciences, Inc
Dr. Reddy’s Laboratories Ltd.
Genor BioPharma Co. Ltd
Intas Pharmaceuticals Limited
Novartis AG
Pfizer, Inc.
Reliance Life Sciences

Market Segment by Regions, regional analysis covers


North America United States, Canada and Mexico
Europe Germany, France, UK, Russia and Italy
Asia-Pacific China, Japan, Korea, India and Southeast Asia
South America Brazil, Argentina, Colombia etc.
Middle East and Africa Saudi Arabia, UAE, Egypt, Nigeria and South Africa

Market Segment by Type, covers


Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others

Market Segment by Applications, can be divided into


Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others

There are 15 Chapters to deeply display the global Biosimilar market.
Chapter 1, to describe Biosimilar Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biosimilar, with sales, revenue, and price of Biosimilar, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biosimilar, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biosimilar sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents

1 Market Overview
1.1 Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Human Growth Hormones
1.2.2 Monoclonal Antibodies
1.2.3 Insulin
1.2.4 Peptides
1.2.5 Erythropoietin
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Chronic and Autoimmune Diseases
1.3.3 Growth Hormone Deficiency
1.3.4 Infectious Diseases
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America United States, Canada and Mexico
1.4.1.1 United States Market States and Outlook 2013-2023
1.4.1.2 Canada Market States and Outlook 2013-2023
1.4.1.3 Mexico Market States and Outlook 2013-2023
1.4.2 Europe Germany, France, UK, Russia and Italy
1.4.2.1 Germany Market States and Outlook 2013-2023
1.4.2.2 France Market States and Outlook 2013-2023
1.4.2.3 UK Market States and Outlook 2013-2023
1.4.2.4 Russia Market States and Outlook 2013-2023
1.4.2.5 Italy Market States and Outlook 2013-2023
1.4.3 Asia-Pacific China, Japan, Korea, India and Southeast Asia
1.4.3.1 China Market States and Outlook 2013-2023
1.4.3.2 Japan Market States and Outlook 2013-2023
1.4.3.3 Korea Market States and Outlook 2013-2023
1.4.3.4 India Market States and Outlook 2013-2023
1.4.3.5 Southeast Asia Market States and Outlook 2013-2023
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook 2013-2023
1.4.4.2 Egypt Market States and Outlook 2013-2023
1.4.4.3 Saudi Arabia Market States and Outlook 2013-2023
1.4.4.4 South Africa Market States and Outlook 2013-2023
1.4.4.5 Nigeria Market States and Outlook 2013-2023
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan plc
2.1.1 Business Overview
2.1.2 Biosimilar Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.2 BIOCAD
2.2.1 Business Overview
2.2.2 Biosimilar Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.3 Biocon
2.3.1 Business Overview
2.3.2 Biosimilar Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.4 BioXpress Therapeutics SA
2.4.1 Business Overview
2.4.2 Biosimilar Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BioXpress Therapeutics SA Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.5 Boehringer Ingelheim GmbH
2.5.1 Business Overview
2.5.2 Biosimilar Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim GmbH Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.6 Celltrion Inc.
2.6.1 Business Overview
2.6.2 Biosimilar Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Celltrion Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.7 Coherus BioSciences, Inc
2.7.1 Business Overview
2.7.2 Biosimilar Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Coherus BioSciences, Inc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.8 Dr. Reddy’s Laboratories Ltd.
2.8.1 Business Overview
2.8.2 Biosimilar Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dr. Reddy’s Laboratories Ltd. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.9 Genor BioPharma Co. Ltd
2.9.1 Business Overview
2.9.2 Biosimilar Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Genor BioPharma Co. Ltd Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.10 Intas Pharmaceuticals Limited
2.10.1 Business Overview
2.10.2 Biosimilar Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.11 Novartis AG
2.11.1 Business Overview
2.11.2 Biosimilar Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Novartis AG Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.12 Pfizer, Inc.
2.12.1 Business Overview
2.12.2 Biosimilar Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Pfizer, Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.13 Reliance Life Sciences
2.13.1 Business Overview
2.13.2 Biosimilar Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Reliance Life Sciences Biosimilar Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
3 Global Biosimilar Sales, Revenue, Market Share and Competition by Manufacturer 2016-2017
3.1 Global Biosimilar Sales and Market Share by Manufacturer 2016-2017
3.2 Global Biosimilar Revenue and Market Share by Manufacturer 2016-2017
3.3 Market Concentration Rate
3.3.1 Top 3 Biosimilar Manufacturer Market Share in 2017
3.3.2 Top 6 Biosimilar Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Biosimilar Market Analysis by Regions
4.1 Global Biosimilar Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilar Sales and Market Share by Regions 2013-2018
4.1.2 Global Biosimilar Revenue and Market Share by Regions 2013-2018
4.2 North America Biosimilar Sales and Growth Rate 2013-2018
4.3 Europe Biosimilar Sales and Growth Rate 2013-2018
4.4 Asia-Pacific Biosimilar Sales and Growth Rate 2013-2018
4.5 South America Biosimilar Sales and Growth Rate 2013-2018
4.6 Middle East and Africa Biosimilar Sales and Growth Rate 2013-2018
5 North America Biosimilar by Countries
5.1 North America Biosimilar Sales, Revenue and Market Share by Countries
5.1.1 North America Biosimilar Sales and Market Share by Countries 2013-2018
5.1.2 North America Biosimilar Revenue and Market Share by Countries 2013-2018
5.2 United States Biosimilar Sales and Growth Rate 2013-2018
5.3 Canada Biosimilar Sales and Growth Rate 2013-2018
5.4 Mexico Biosimilar Sales and Growth Rate 2013-2018
6 Europe Biosimilar by Countries
6.1 Europe Biosimilar Sales, Revenue and Market Share by Countries
6.1.1 Europe Biosimilar Sales and Market Share by Countries 2013-2018
6.1.2 Europe Biosimilar Revenue and Market Share by Countries 2013-2018
6.2 Germany Biosimilar Sales and Growth Rate 2013-2018
6.3 UK Biosimilar Sales and Growth Rate 2013-2018
6.4 France Biosimilar Sales and Growth Rate 2013-2018
6.5 Russia Biosimilar Sales and Growth Rate 2013-2018
6.6 Italy Biosimilar Sales and Growth Rate 2013-2018
7 Asia-Pacific Biosimilar by Countries
7.1 Asia-Pacific Biosimilar Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biosimilar Sales and Market Share by Countries 2013-2018
7.1.2 Asia-Pacific Biosimilar Revenue and Market Share by Countries 2013-2018
7.2 China Biosimilar Sales and Growth Rate 2013-2018
7.3 Japan Biosimilar Sales and Growth Rate 2013-2018
7.4 Korea Biosimilar Sales and Growth Rate 2013-2018
7.5 India Biosimilar Sales and Growth Rate 2013-2018
7.6 Southeast Asia Biosimilar Sales and Growth Rate 2013-2018
8 South America Biosimilar by Countries
8.1 South America Biosimilar Sales, Revenue and Market Share by Countries
8.1.1 South America Biosimilar Sales and Market Share by Countries 2013-2018
8.1.2 South America Biosimilar Revenue and Market Share by Countries 2013-2018
8.2 Brazil Biosimilar Sales and Growth Rate 2013-2018
8.3 Argentina Biosimilar Sales and Growth Rate 2013-2018
8.4 Colombia Biosimilar Sales and Growth Rate 2013-2018
9 Middle East and Africa Biosimilar by Countries
9.1 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biosimilar Sales and Market Share by Countries 2013-2018
9.1.2 Middle East and Africa Biosimilar Revenue and Market Share by Countries 2013-2018
9.2 Saudi Arabia Biosimilar Sales and Growth Rate 2013-2018
9.3 UAE Biosimilar Sales and Growth Rate 2013-2018
9.4 Egypt Biosimilar Sales and Growth Rate 2013-2018
9.5 Nigeria Biosimilar Sales and Growth Rate 2013-2018
9.6 South Africa Biosimilar Sales and Growth Rate 2013-2018
10 Global Biosimilar Market Segment by Type
10.1 Global Biosimilar Sales, Revenue and Market Share by Type 2013-2018
10.1.1 Global Biosimilar Sales and Market Share by Type 2013-2018
10.1.2 Global Biosimilar Revenue and Market Share by Type 2013-2018
10.2 Human Growth Hormones Sales Growth and Price
10.2.1 Global Human Growth Hormones Sales Growth 2013-2018
10.2.2 Global Human Growth Hormones Price 2013-2018
10.3 Monoclonal Antibodies Sales Growth and Price
10.3.1 Global Monoclonal Antibodies Sales Growth 2013-2018
10.3.2 Global Monoclonal Antibodies Price 2013-2018
10.4 Insulin Sales Growth and Price
10.4.1 Global Insulin Sales Growth 2013-2018
10.4.2 Global Insulin Price 2013-2018
10.5 Peptides Sales Growth and Price
10.5.1 Global Peptides Sales Growth 2013-2018
10.5.2 Global Peptides Price 2013-2018
10.6 Erythropoietin Sales Growth and Price
10.6.1 Global Erythropoietin Sales Growth 2013-2018
10.6.2 Global Erythropoietin Price 2013-2018
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth 2013-2018
10.7.2 Global Others Price 2013-2018
11 Global Biosimilar Market Segment by Application
11.1 Global Biosimilar Sales Market Share by Application 2013-2018
11.2 Oncology Sales Growth 2013-2018
11.3 Chronic and Autoimmune Diseases Sales Growth 2013-2018
11.4 Growth Hormone Deficiency Sales Growth 2013-2018
11.5 Infectious Diseases Sales Growth 2013-2018
11.6 Others Sales Growth 2013-2018
12 Biosimilar Market Forecast 2018-2023
12.1 Global Biosimilar Sales, Revenue and Growth Rate 2018-2023
12.2 Biosimilar Market Forecast by Regions 2018-2023
12.2.1 North America Biosimilar Market Forecast 2018-2023
12.2.2 Europe Biosimilar Market Forecast 2018-2023
12.2.3 Asia-Pacific Biosimilar Market Forecast 2018-2023
12.2.4 South America Biosimilar Market Forecast 2018-2023
12.2.5 Middle East and Africa Biosimilar Market Forecast 2018-2023
12.3 Biosimilar Market Forecast by Type 2018-2023
12.3.1 Global Biosimilar Sales Forecast by Type 2018-2023
12.3.2 Global Biosimilar Market Share Forecast by Type 2018-2023
12.4 Biosimilar Market Forecast by Application 2018-2023
12.4.1 Global Biosimilar Sales Forecast by Application 2018-2023
12.4.2 Global Biosimilar Market Share Forecast by Application 2018-2023
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures

Figure Biosimilar Picture
Table Product Specifications of Biosimilar
Figure Global Sales Market Share of Biosimilar by Types in 2017
Table Biosimilar Types for Major Manufacturers
Figure Human Growth Hormones Picture
Figure Monoclonal Antibodies Picture
Figure Insulin Picture
Figure Peptides Picture
Figure Erythropoietin Picture
Figure Others Picture
Figure Biosimilar Sales Market Share by Applications in 2017
Figure Oncology Picture
Figure Chronic and Autoimmune Diseases Picture
Figure Growth Hormone Deficiency Picture
Figure Infectious Diseases Picture
Figure Others Picture
Figure United States Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure France Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure UK Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure China Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure India Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Table Allergan plc Basic Information, Manufacturing Base and Competitors
Table Allergan plc Biosimilar Type and Applications
Table Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BIOCAD Basic Information, Manufacturing Base and Competitors
Table BIOCAD Biosimilar Type and Applications
Table BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Biosimilar Type and Applications
Table Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BioXpress Therapeutics SA Basic Information, Manufacturing Base and Competitors
Table BioXpress Therapeutics SA Biosimilar Type and Applications
Table BioXpress Therapeutics SA Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim GmbH Biosimilar Type and Applications
Table Boehringer Ingelheim GmbH Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celltrion Inc. Basic Information, Manufacturing Base and Competitors
Table Celltrion Inc. Biosimilar Type and Applications
Table Celltrion Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Coherus BioSciences, Inc Basic Information, Manufacturing Base and Competitors
Table Coherus BioSciences, Inc Biosimilar Type and Applications
Table Coherus BioSciences, Inc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Dr. Reddy’s Laboratories Ltd. Basic Information, Manufacturing Base and Competitors
Table Dr. Reddy’s Laboratories Ltd. Biosimilar Type and Applications
Table Dr. Reddy’s Laboratories Ltd. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genor BioPharma Co. Ltd Basic Information, Manufacturing Base and Competitors
Table Genor BioPharma Co. Ltd Biosimilar Type and Applications
Table Genor BioPharma Co. Ltd Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Intas Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table Intas Pharmaceuticals Limited Biosimilar Type and Applications
Table Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Biosimilar Type and Applications
Table Novartis AG Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer, Inc. Biosimilar Type and Applications
Table Pfizer, Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Reliance Life Sciences Basic Information, Manufacturing Base and Competitors
Table Reliance Life Sciences Biosimilar Type and Applications
Table Reliance Life Sciences Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Biosimilar Sales by Manufacturer (2016-2017)
Figure Global Biosimilar Sales Market Share by Manufacturer in 2016
Figure Global Biosimilar Sales Market Share by Manufacturer in 2017
Table Global Biosimilar Revenue by Manufacturer (2016-2017)
Figure Global Biosimilar Revenue Market Share by Manufacturer in 2016
Figure Global Biosimilar Revenue Market Share by Manufacturer in 2017
Figure Top 3 Biosimilar Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Biosimilar Manufacturer (Revenue) Market Share in 2017
Figure Global Biosimilar Sales and Growth Rate (2013-2018)
Figure Global Biosimilar Revenue and Growth Rate (2013-2018)
Table Global Biosimilar Sales by Regions (2013-2018)
Table Global Biosimilar Sales Market Share by Regions (2013-2018)
Table Global Biosimilar Revenue by Regions (2013-2018)
Figure Global Biosimilar Revenue Market Share by Regions in 2013
Figure Global Biosimilar Revenue Market Share by Regions in 2017
Figure North America Biosimilar Sales and Growth Rate (2013-2018)
Figure Europe Biosimilar Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Biosimilar Sales and Growth Rate (2013-2018)
Figure South America Biosimilar Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Biosimilar Sales and Growth Rate (2013-2018)
Figure North America Biosimilar Revenue and Growth Rate (2013-2018)
Table North America Biosimilar Sales by Countries (2013-2018)
Table North America Biosimilar Sales Market Share by Countries (2013-2018)
Figure North America Biosimilar Sales Market Share by Countries in 2013
Figure North America Biosimilar Sales Market Share by Countries in 2017
Table North America Biosimilar Revenue by Countries (2013-2018)
Table North America Biosimilar Revenue Market Share by Countries (2013-2018)
Figure North America Biosimilar Revenue Market Share by Countries in 2013
Figure North America Biosimilar Revenue Market Share by Countries in 2017
Figure United States Biosimilar Sales and Growth Rate (2013-2018)
Figure Canada Biosimilar Sales and Growth Rate (2013-2018)
Figure Mexico Biosimilar Sales and Growth Rate (2013-2018)
Figure Europe Biosimilar Revenue and Growth Rate (2013-2018)
Table Europe Biosimilar Sales by Countries (2013-2018)
Table Europe Biosimilar Sales Market Share by Countries (2013-2018)
Table Europe Biosimilar Revenue by Countries (2013-2018)
Figure Europe Biosimilar Revenue Market Share by Countries in 2016
Figure Europe Biosimilar Revenue Market Share by Countries in 2017
Figure Germany Biosimilar Sales and Growth Rate (2013-2018)
Figure UK Biosimilar Sales and Growth Rate (2013-2018)
Figure France Biosimilar Sales and Growth Rate (2013-2018)
Figure Russia Biosimilar Sales and Growth Rate (2013-2018)
Figure Italy Biosimilar Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Biosimilar Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Biosimilar Sales by Countries (2013-2018)
Table Asia-Pacific Biosimilar Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Biosimilar Sales Market Share by Countries 2017
Table Asia-Pacific Biosimilar Revenue by Countries (2013-2018)
Figure Asia-Pacific Biosimilar Revenue Market Share by Countries 2017
Figure China Biosimilar Sales and Growth Rate (2013-2018)
Figure Japan Biosimilar Sales and Growth Rate (2013-2018)
Figure Korea Biosimilar Sales and Growth Rate (2013-2018)
Figure India Biosimilar Sales and Growth Rate (2013-2018)
Figure Southeast Asia Biosimilar Sales and Growth Rate (2013-2018)
Figure South America Biosimilar Revenue and Growth Rate (2013-2018)
Table South America Biosimilar Sales by Countries (2013-2018)
Table South America Biosimilar Sales Market Share by Countries (2013-2018)
Figure South America Biosimilar Sales Market Share by Countries in 2017
Table South America Biosimilar Revenue by Countries (2013-2018)
Table South America Biosimilar Revenue Market Share by Countries (2013-2018)
Figure South America Biosimilar Revenue Market Share by Countries in 2017
Figure Brazil Biosimilar Sales and Growth Rate (2013-2018)
Figure Argentina Biosimilar Sales and Growth Rate (2013-2018)
Figure Colombia Biosimilar Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Biosimilar Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Biosimilar Sales by Countries (2013-2018)
Table Middle East and Africa Biosimilar Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Biosimilar Sales Market Share by Countries in 2017
Table Middle East and Africa Biosimilar Revenue by Countries (2013-2018)
Table Middle East and Africa Biosimilar Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Biosimilar Revenue Market Share by Countries in 2013
Figure Middle East and Africa Biosimilar Revenue Market Share by Countries in 2017
Figure Saudi Arabia Biosimilar Sales and Growth Rate (2013-2018)
Figure UAE Biosimilar Sales and Growth Rate (2013-2018)
Figure Egypt Biosimilar Sales and Growth Rate (2013-2018)
Figure Nigeria Biosimilar Sales and Growth Rate (2013-2018)
Figure South Africa Biosimilar Sales and Growth Rate (2013-2018)
Table Global Biosimilar Sales by Type (2013-2018)
Table Global Biosimilar Sales Share by Type (2013-2018)
Table Global Biosimilar Revenue by Type (2013-2018)
Table Global Biosimilar Revenue Share by Type (2013-2018)
Figure Global Human Growth Hormones Sales Growth (2013-2018)
Figure Global Human Growth Hormones Price (2013-2018)
Figure Global Monoclonal Antibodies Sales Growth (2013-2018)
Figure Global Monoclonal Antibodies Price (2013-2018)
Figure Global Insulin Sales Growth (2013-2018)
Figure Global Insulin Price (2013-2018)
Figure Global Peptides Sales Growth (2013-2018)
Figure Global Peptides Price (2013-2018)
Figure Global Erythropoietin Sales Growth (2013-2018)
Figure Global Erythropoietin Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Biosimilar Sales by Application (2013-2018)
Table Global Biosimilar Sales Share by Application (2013-2018)
Figure Global Chronic and Autoimmune Diseases Sales Growth (2013-2018)
Figure Global Growth Hormone Deficiency Sales Growth (2013-2018)
Figure Global Infectious Diseases Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Biosimilar Sales, Revenue and Growth Rate (2018-2023)
Table Global Biosimilar Sales Forecast by Regions (2018-2023)
Table Global Biosimilar Market Share Forecast by Regions (2018-2023)
Figure North America Sales Biosimilar Market Forecast (2018-2023)
Figure Europe Sales Biosimilar Market Forecast (2018-2023)
Figure Asia-Pacific Sales Biosimilar Market Forecast (2018-2023)
Figure South America Sales Biosimilar Market Forecast (2018-2023)
Figure Middle East and Africa Sales Biosimilar Market Forecast (2018-2023)
Table Global Biosimilar Sales Forecast by Type (2018-2023)
Table Global Biosimilar Market Share Forecast by Type (2018-2023)
Table Global Biosimilar Sales Forecast by Application (2018-2023)
Table Global Biosimilar Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....